MARSHALL WACE, LLP - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTACW and the CUSIP is 58507N113. A total of 36 filers reported holding MEDTECH ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q1 2023$489,261
+2.7%
47,4550.0%0.00%0.0%
Q4 2022$476,448
+0.9%
47,4550.0%0.00%0.0%
Q3 2022$472,000
+1.1%
47,4550.0%0.00%0.0%
Q2 2022$467,000
+0.2%
47,4550.0%0.00%0.0%
Q1 2022$466,000
-1.1%
47,4550.0%0.00%0.0%
Q4 2021$471,00047,4550.00%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q4 2021
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 500,000$4,900,0000.26%
ANGELO GORDON & CO., L.P. 95,808$939,0000.11%
CastleKnight Management LP 46,371$454,0000.06%
Radcliffe Capital Management, L.P. 138,194$1,354,0000.03%
Q Global Advisors, LLC 49,561$13,0000.01%
MYDA Advisors LLC 42,949$11,0000.00%
Magnetar Financial LLC 1,243,264$315,0000.00%
Kepos Capital LP 145,000$37,0000.00%
Bracebridge Capital, LLC 98,857$25,0000.00%
SPRING CREEK CAPITAL LLC 167,566$42,0000.00%
View complete list of MEDTECH ACQUISITION CORP shareholders